Hepatitis B prevention, diagnosis, treatment and precaution

2^nd international conference virology and infectious disease

Date: September 3-4, 2019

Venue: London, UK

URL: https://bit.ly/2QeWHY3

Hepatitis B prevention, diagnosis, treatment and precaution

Hepatitis B virus (HBV) infection may be a major reason for wellness and mortality worldwide. Chronic serum hepatitis (CHB) infection is expounded with Associate in Nursing increased risk of liver disease, viscose compensating and malignant hematoma (HCC). The chance of developing CHB is related to the age at that infection is acquired; the risk being lowest in adults and >90% in neonates whose mothers are serum hepatitis e matter positive. Treatment of CHB infection aims to clear HBV DNA and stop the development of complications.

There are currently seven drugs available for the treatment of CHB: 5 nucleus (t) ide analogues and 2 interferon-based therapies. Long-term treatment is often required, and also the call to treat relies on clinical assessment as well as the phase of CHB infection and the presence and extent of liver harm. a safe and effective HBV vaccine has been offered since the first 1980s.

Vaccination plays a central role in HBV bar strategies worldwide, and a decline within the incidence and prevalence of HBV infection following the introduction of universal HBV vaccination programmes has been ascertained in many countries as well as the USA and elements of South East Asia and Europe.

 Post-exposure bar (PEP) with HBV vaccine +/− hepatitis b Ig is very effective in preventing mother to child transmission and in preventing transmission following sharps injuries, sexual contact and different exposures to infected blood and body fluids.

Transmission of HBV within the health care setting has become Associate in nursing more and rarer event in developed nations. However, it remains a big risk in developing countries reflective the upper prevalence of CHB, limited access to HBV vaccination and liveliness and a lack of adherence to plain infection control precautions.

To know more about virology and infectious disease, attend an event on Viral immunology at Virology 2019 conference

Contact details:
Clara Charlotte
Program Manager | virology 2019
Email: virology@microbioconferences.com
Phone: +44 20 3769 1755